Continuing Medical and Professional Education: 2025 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR are sponsored by the Medical College of Wisconsin.
ACCME Accreditation Statement: The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians.
AMA Credit Designation: The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Tandem Wednesday Luncheon Symposium: A Balancing Act: Safety and Success in CMV Management for HCT Patients
Ballroom A
This activity is supported by Takeda Pharmaceuticals U.S.A., Inc.
Tandem Wednesday Luncheon Symposium: The Innovation Intersection in B-Cell Cancers: Navigating Choices With Modern Targeted Strategies, Cellular Therapy, and HCT
Ballroom C
This activity is supported by individual educational grants from AstraZeneca, Bristol Myers Squibb, and Lilly.
Tandem Thursday Breakfast Symposium: Innovation Takes Shape in SCD: Rewriting Management Principles with Gene Therapy and Revisiting the Role of HSCT
Ballroom A
This activity is supported by an educational grant from Vertex Pharmaceuticals.
Tandem Thursday Breakfast Symposium: Unlocking Efficacy Expanding Access to CAR-T in Lymphoma and Myeloma: From Practice-Changing Evidence to Real-World & Outpatient Experiences
Ballroom C
This activity is supported through educational grants from Bristol Myers Squibb, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), Legend Biotech, and Novartis Pharmaceuticals Corporation.
Tandem Thursday Luncheon Symposium: Partnering Innovative Strategies With Alternative Donor Sources to Advance Allogeneic HCT Outcomes
Ballroom A
This activity is supported by an educational grant from Gamida Cell.
Tandem Friday Breakfast Symposium: The Good, the Bad, and the GVHD: Leveraging Modern Therapeutis to Improve Post-Transplant Outcomes
Ballroom A
This activity is supported by individual educational grants from Incyte Corporation and Mallinckrodt Pharmaceuticals.
Tandem Friday Luncheon Symposium: A Roadmap for Managing Post-HCT VOD/SOS: Team-Based Guidance on Capturing, Assessing, and Managing Diverse Presentations
Ballroom A
This activity is supported by an educational grant from Jazz Pharmaceuticals.